Epidiolex is a medical Cannabinoid product produced by GW Pharmaceuticals. It was approved by the FDA in the USA, and is permitted to be prescribed to patients suffering from rare forms of Epilepsy.

The product is a medical CBD product, which hasn’t been authorised for prescription in the UK and Europe. However, an application has been made to the European Medicines Agency (EMA)